ENHANCED SYMPTOM RELIEF IN ALLERGIC RHINITIS THROUGH COMBINED CHEMICAL CAUTERY AND INTRANASAL STEROID THERAPY: A RANDOMIZED CONTROL STUDY

Abstract

Introduction: Allergic rhinitis is a common condition affecting a significant portion of the population, leading to reduced quality of life and work performance. Traditional treatments often fall short of providing long-term relief, necessitating the exploration of alternative approaches such as chemical cautery of inferior turbinates. The study aims to evaluate the effectiveness of this approach in alleviating symptoms of allergic rhinitis. Methodology and Research Design: The study is a randomized controlled trial conducted at Saveetha Medical College and Hospital. Patients meeting specific criteria are divided into three groups 22 subjects in each: Group A receiving chemical cautery alone, Group B receiving steroid nasal spray alone, and Group C receiving a combination of both. Symptom severity is assessed before treatment and at 3-month and 6-month follow-ups. Statistical analysis is conducted using ANOVA, chi-square tests, and post hoc tests. Results: No significant differences are observed in age or gender distribution among the three groups. Before treatment, there are no significant differences in symptom severity among the groups. However, at the 6-month follow-up, significant improvements are seen in the combined treatment group C compared to the other two groups. Adverse effects are minimal, with pharyngitis being the most common complaint. Discussion: The combined approach of chemical cautery and steroid spray demonstrates superior efficacy in reducing symptoms of allergic rhinitis and inferior turbinate hypertrophy. This combined treatment offers promise for patients with higher initial symptom severity grades. Chemical cautery provides a viable alternative to surgical interventions, with minimal adverse effects. Conclusion: The study concludes that the combined treatment of chemical cautery of the inferior turbinate and steroid spray effectively alleviates symptoms of allergic rhinitis and inferior turbinate hypertrophy. This approach holds the potential for improving symptom control and quality of life in affected patients. The study provides valuable insights into a novel treatment approach for allergic rhinitis, paving the way for further research and clinical application.